Nephrologische Gemeinschaftspraxis

What Nephrologische Gemeinschaftspraxis does

operasan Holding GmbH, operating under the brand "operasan," is a German private healthcare group that runs a network of more than 30 dialysis and nephrology centers across Germany, treating over 24,000 patients annually with kidney disease, hypertension, diabetes, and lipid metabolism disorders. The group employs approximately 750 full-time staff and was founded in 1999 with headquarters registered in Büren and operational headquarters in Paderborn. Its growth model is anchored on acquiring independent nephrology practices from retiring or consolidating physicians, integrating them into a holding structure of wholly-owned MVZ (Medizinisches Versorgungszentrum) subsidiaries while preserving local brand identity and physician autonomy.

The core technology stack consists of clinical dialysis equipment from Fresenius (5008 and 4008 series) and B. Braun (Dialog+), supporting hemodialysis (HD), hemodiafiltration (HDF), peritoneal dialysis (PD) including CAPD/APD, and home hemodialysis. Beyond core dialysis, the centers deliver specialized nephrology outpatient services, lipid apheresis, plasma separation for autoimmune and neurological conditions, transplantation preparation and aftercare, and advanced diagnostics such as Body Composition Monitoring (BCM), Pulse Wave Analysis (PWA), and telemedicine-based remote monitoring of ECG, blood pressure, and weight. Service quality is anchored by an Ärztlicher Beirat (Medical Advisory Board) led by senior nephrologists including Dr. Theo Busch and Dr. Anita Hansen, and DIN EN ISO 9001:2008 certification at the Nürnberg center.

Revenue is generated principally through recurring statutory and private health insurance reimbursements under Germany's GKV/DRG framework for in-center and home dialysis, nephrology consultations, and apheresis procedures. The go-to-market is sales-led and referral-driven: patient acquisition flows from general practitioners, specialists, and hospital partnerships (e.g., Universitätsmedizin Göttingen, Universitätsklinikum Münster, Universitätsklinikum Essen, Klinikum Westfalen), while physician acquisition flows from succession-driven practice sales. There is no public pricing; reimbursement rates are negotiated collectively with German health insurers, and pricing is not publicly disclosed.

Name

Nephrologische Gemeinschaftspraxis

Legal name

operasan Holding GmbH

Website

https://dialyse-roth.de

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

operasan Holding GmbH operates a network of 30+ dialysis and nephrology centers across Germany, providing hemodialysis, home dialysis, apheresis, and specialist nephrology care to 24,000+ patients annually through acquired independent practices and wholly-owned MVZ subsidiaries.

Ownership category

akta.pro rank

Product category

Dialysis and Nephrology Services

NAICS

Kidney Dialysis Centers (621492), Offices of Physicians (6211), Home Health Care Services (62161)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industries

Home Dialysis Programs (Home HD/PD Training & Support) (HLAKAHAK), Outpatient Dialysis & Kidney Care Centers (HLAFABAE)

Keywords

• Dialysis services
• Nephrology care
• Kidney replacement therapy
• Home hemodialysis
• Specialist medical practice

Headquarters

HQ city

Büren

HQ country

Germany

HQ region

Europe

Offices18 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Dialysis Treatment Services: Revenue generated from providing hemodialysis, hemodiafiltration, and peritoneal dialysis treatments to patients with kidney disease. Covered through statutory and private health insurance in Germany.
2. Nephrology Outpatient Clinic Services: Specialist nephrology consultations including early detection of kidney disease, hypertension management, diabetes care, and lipidology services.
3. Practice Acquisition Integration: Nephrology practices are acquired and integrated into the operasan group, with selling physicians receiving purchase price and continued employment with potential group participation.
4. Specialized Treatments: Additional revenue streams include lipid apheresis, plasma separation for autoimmune conditions, transplantation preparation and follow-up care.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Operasan operates a network of 30+ dialysis and nephrology centers across Germany, delivering the full kidney-care treatment chain from early disease detection through home dialysis. Core services include hemodialysis, hemodiafiltration, peritoneal dialysis, transplant preparation and aftercare, lipid apheresis, plasma separation, and hypertension/diabetes management, treating 24,000+ patients annually.

Product overview

Operasan Holding GmbH operates a network of 30 kidney and dialysis centers across Germany, providing comprehensive nephrological care. The core offering is dialyse@home, an integrated treatment chain that coordinates nephrology outpatient clinics, all kidney replacement therapies (hemodialysis, hemodiafiltration, peritoneal dialysis, home hemodialysis), transplant preparation and aftercare, and hospital cooperation. The company offers specialized services including lipid apheresis, plasma separation, and advanced diagnostics such as pulse wave analysis and body composition monitoring. Dialysis treatments are provided using equipment from manufacturers such as Fresenius and Braun. Centers are positioned as competence centers for all therapeutic forms of kidney medicine and replacement therapy, treating annually over 24,000 patients with nephrological conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• dialyse@home (Integrated Treatment Chain) A comprehensive nephrological treatment program that integrates cooperation with general practitioners and specialists, nephrology outpatient clinics, kidney replacement therapies, and hospital partnerships, with the goal of improving patient quality of life and promoting home dialysis adoption.
• Hemodialysis (Hämodialyse) Blood-purification procedure where blood is filtered outside the body through a synthetic membrane and returned, typically performed three times weekly for four to six hours at operasan's dialysis centers.
• Hemodiafiltration (Hämodiafiltration) A procedure similar to hemodialysis that filters larger substances from blood by pressing large quantities of plasma water through a membrane to remove slowly diffusing toxic substances.
• Peritoneal Dialysis (Peritonealdialyse) Abdominal membrane dialysis using the peritoneum as a natural filter, offered as CAPD (manual exchange) or APD (automated via cycler machine), suitable for mobile patients.
• Home Hemodialysis (Heimhämodialyse) Home-based dialysis where patients self-administer treatment using operasan-provided equipment including dialysis machine, dialysis chair/bed, and water treatment system, allowing self-determined treatment frequency.
• Nephrology Outpatient Clinic (Nephrologische Ambulanz) Early detection and progression inhibition of kidney diseases to preserve natural kidney function, offering first appointments within 14 days and comprehensive patient education on treatment options including transplantation.
• Transplant Preparation and Aftercare Preparation of patients for kidney transplantation and ongoing care post-transplantation, delivered in cooperation with transplant centers.
• Lipid Apheresis (Lipidapherese) Procedure for removal of lipid metabolism products for high-risk cardiovascular patients, performed every two weeks or weekly in severe cases.
• Plasma Separation (Plasmaseparation) Blood plasma exchange treatment for rheumatological and neurological conditions to remove pathogenic antibodies, conducted in cooperation with neurological clinics.
• Vacation/Guest Dialysis (Urlaubsdialyse) Guest dialysis services for vacation patients, including short-term availability at various operasan centers.
• Vascular Access Management (Shunt-Diagnostik und -Therapie) Specialized vascular and dialysis shunt diagnostics and treatment for patients with vascular access problems.

Quantifiable outcome

• 24,000+ patients treated annually at 30 locations
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

15 partnerships are on record, tiered core and minor.

• Universitätsmedizin Göttingen (UMG) - Klinik für Nephrologie und RheumatologiecoreStrategic or Co-development PartnerClose cooperation between UMG's nephrology department and operasan's Nieren-Rheuma-Zentrum Göttingen for optimal patient care. Includes joint specialist training programs to ensure high quality of the next generation of nephrologists. Prof. Dr. med. Michael Zeisberg serves as Director of the cooperating clinic.
• Klinikum Westfalen - Hellmig Krankenhaus KamencoreStrategic or Co-development PartnerHospital partnership for nephrology patient care and treatment coordination.
• Katharinen Hospital UnnaminorStrategic or Co-development PartnerRegional hospital partnership for patient referrals and specialized care.
• St.-Marien-Hospital LünenminorStrategic or Co-development PartnerCooperation for neurology and plasma separation treatments including Guillain-Barré syndrome and myasthenic crisis.
• St. Barbara-Klinik Hamm-HeessenminorStrategic or Co-development PartnerRegional hospital partnership for nephrology patient coordination.
• Herz-Jesu-Krankenhaus Münster-HiltrupminorStrategic or Co-development PartnerRegional hospital partnership for cardiac and nephrology care coordination.
• Universitätsklinikum MünstercoreStrategic or Co-development PartnerUniversity hospital partnership for advanced nephrology cases and transplantation services.
• Universitätsklinikum Knappschaftskrankenhaus Bochum-LangendreerminorStrategic or Co-development PartnerUniversity hospital partnership for nephrology patient referrals.
• Marienhospital HerneminorStrategic or Co-development PartnerRegional hospital partnership for nephrology patient care.
• Universitätsklinikum EssencoreStrategic or Co-development PartnerUniversity clinic partnership for complex nephrology cases and transplantation.
• St. Theresienkrankenhaus NürnbergcoreStrategic or Co-development PartnerClose cooperation with this acute care hospital for inpatient consultations and dialysis treatment of hospitalized patients.
• Marienhaus Klinikum St. Wendel-OttweilercoreStrategic or Co-development PartnerHospital partnership for acute and chronic dialysis treatment and nephrology consultations.
• MediClin Bosenberg Kliniken St. WendelminorStrategic or Co-development PartnerClinic partnership for nephrology patient care coordination.
• Johanniter-Krankenhaus Duisburg-RheinhausencoreStrategic or Co-development PartnerNephrologisches Zentrum operating within this hospital for acute care dialysis patients.
• St. Josef Krankenhaus MoerscoreStrategic or Co-development PartnerNephrologisches Zentrum operating within this hospital for acute care dialysis patients.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• U.S. Renal Care: Mid-sized dialysis services provider in the US. PE-backed roll-up strategy similar to operasan's German practice acquisition model. Useful comparison for capital structure and growth trajectory benchmarks in dialysis services.
• Innovative Renal Care: PE-backed US dialysis provider offering in-center and home dialysis services. Similar growth-by-acquisition model as operasan's, with comparable patient demographic and service mix. Strategic parallel for understanding roll-up economics in dialysis.

Direct peers

• B. Braun Avitum: Operates dialysis centers across Europe as part of B. Braun's medical division. Operasan uses B. Braun Dialog+ systems, making B. Braun Avitum both a vendor and a direct services competitor. Highly comparable in service delivery and patient base.
• Diaverum: Global renal care provider offering in-center and home dialysis, nephrology outpatient services, and vascular access care across Europe, Middle East, and Latin America. Direct dialysis services peer with similar patient base and service portfolio. Operasan and Diaverum both operate competitor networks in Germany.
• KfH Kuratorium für Dialyse und Nierentransplantation: Non-profit provider of dialysis and kidney transplantation services in Germany, operating one of the largest networks of dialysis centers in the country. Direct comparison as both organizations operate outpatient dialysis centers serving the same German patient population with comparable services.
• PHV (Patienten-Heimversorgung): German dialysis services provider offering home dialysis and center-based dialysis. Direct peer with overlapping patient base, services, and geography. Heavily focused on home dialysis, complementing operasan's dialyse@home strategy.

Regional players

• Dialysezentrum Bern (Lindenhofgruppe): Swiss dialysis services provider operating multiple centers in Switzerland. Similar service model and patient base to operasan, but in a different national reimbursement system. Geographic peer for European dialysis services consolidation.

Others

• MediClin AG: German healthcare provider operating hospitals and clinics including nephrology services. Operasan partners with similar clinic networks. Adjacent healthcare services operator in Germany with shared patient referral pools and overlapping clinical footprint.

Broad incumbents

• Fresenius Medical Care: Global dialysis services market leader (NephroCare brand) operating thousands of dialysis centers worldwide including in Germany. Directly comparable end customer (dialysis patients), services (HD, HDF, PD, home dialysis), and equipment supplier (operasan uses Fresenius systems). Operasan is a smaller regional competitor to Fresenius's network.
• DaVita: Global dialysis services provider operating thousands of centers primarily in the US. Operasan operates in different geographies but in the same dialysis services category with the same patient base. Provides scale benchmarking for operasan's service model and reimbursement economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nephrologische-gemeinschaftspraxis

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nephrologische Gemeinschaftspraxis